| __timestamp | Walgreens Boots Alliance, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 54823000000 | 2395000 |
| Thursday, January 1, 2015 | 76691000000 | 9057000 |
| Friday, January 1, 2016 | 87477000000 | 393000 |
| Sunday, January 1, 2017 | 89052000000 | 79309000 |
| Monday, January 1, 2018 | 100745000000 | 134428000 |
| Tuesday, January 1, 2019 | 91915000000 | 175431000 |
| Wednesday, January 1, 2020 | 95905000000 | 124165000 |
| Friday, January 1, 2021 | 104442000000 | 121875000 |
| Saturday, January 1, 2022 | 104437000000 | 10114000 |
| Sunday, January 1, 2023 | 112009000000 | 9206000 |
| Monday, January 1, 2024 | 121134000000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding cost dynamics is crucial. Walgreens Boots Alliance, Inc., a retail pharmacy giant, has seen its cost of revenue grow by approximately 121% from 2014 to 2024. This reflects its expansive operations and market reach. In contrast, Wave Life Sciences Ltd., a smaller biotech firm, exhibits a more volatile trend, with costs peaking in 2019 and then declining sharply by 95% by 2023. This disparity highlights the contrasting business models and market strategies of these companies. Walgreens' consistent growth underscores its robust supply chain and market penetration, while Wave's fluctuations may indicate strategic pivots or market challenges. Notably, data for 2024 is missing for Wave, suggesting potential reporting delays or strategic shifts. These insights offer a window into the financial health and strategic directions of these industry players.
Cost of Revenue Trends: Johnson & Johnson vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Amgen Inc. vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Bristol-Myers Squibb Company vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.